FIELD: chemistry.
SUBSTANCE: group of inventions relates to medicine and concerns a salt-free composition of an anti-TFPI antibody for treating hemophilia A or hemophilia B in a patient, including histidine, non-ionic surfactant, sugar or sugar alcohol, arginine, lysine or alanine, methionine and human IgG2 anti-TFPI antibody, containing a light chain comprising the amino acid sequence SEQ ID NO: 1, and a heavy chain comprising the amino acid sequence SEQ ID NO: 2. Where said composition has a pH value that ranges from pH 4.0 to pH 6.0 and where this composition is substantially free of inorganic salts. Group of inventions also relates to a method of treating hemophilia A or hemophilia B in a patient, comprising administering to the patient a therapeutically effective amount of the composition.
EFFECT: group of inventions provides high solubility and stability of the anti-TFPI antibody in the composition.
9 cl, 4 ex, 2 dwg, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
PREPARATIONS OF ANTIBODY TO THE ANTI-PROLACTIN RECEPTOR | 2013 |
|
RU2649372C2 |
CONCENTRATED PROTEIN PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION | 2011 |
|
RU2626512C2 |
COMPOSITIONS CONTAINING ANTIBODY-DRUG CONJUGATES DUOCARMICIN | 2016 |
|
RU2687237C1 |
HIGHLY CONCENTRATED COMPOSITIONS OF ANTIBODIES AND PROTEINS | 2004 |
|
RU2332986C2 |
PHARMACEUTICAL COMPOSITION | 2017 |
|
RU2775944C2 |
LYOPHILIZED IMMUNOCYTOKINE-CONTAINING PREPARATION | 2003 |
|
RU2316348C2 |
COMPOSITIONS OF ANTI-PD-1 ANTIBODIES | 2019 |
|
RU2772781C2 |
STABLE ISOTONIC LYOPHILISED PROTEIN COMPOSITION | 1996 |
|
RU2497500C2 |
NEW STABLE COMPOSITIONS FOR FXIA ANTIBODIES | 2018 |
|
RU2775692C2 |
STABLE ISOTONIC LYOPHILIZED PROTEIN COMPOSITION | 1996 |
|
RU2229288C2 |
Authors
Dates
2019-01-23—Published
2013-08-28—Filed